What's on this Page
Halobetasol Brand Names- BRYHALI | LEXETTE | Ultravate
What is Halobetasol
Halobetasol is a very high potency, topical, fluorinated corticosteroid.
Halobetasol is used to relieve the inflammatory and pruritic manifestations of moderate to severe corticosteroid-responsive dermatoses and psoriasis.
Very high potency topical corticosteroids are used as an alternative to systemic therapy for localized conditions.
Long-term or extensive use can lead to systemic side effects, including hypothalamic-pituitary-adrenal (HPA) axis suppression.
Comparative studies with other very high potency corticosteroids, such as clobetasol or betamethasone dipropionate have shown similar results in the treatment of atopic dermatitis and plaque-type psoriasis.
Combination regimens using calcipotriene and halobetasol have been effective for the treatment of psoriasis.
Indications
- alopecia
- atopic dermatitis
- contact dermatitis
- cutaneous T-cell lymphoma (CTCL)
- dermatitis
- discoid lupus erythematosus
- eczema
- exfoliative dermatitis
- granuloma annulare
- keloids
- lichen planus
- lichen simplex
- lichen striatus
- mycosis fungoides
- necrobiosis lipoidica diabeticorum
- pityriasis rosea
- pompholyx
- prurigo
- pruritus
- psoriasis
- Rhus dermatitis
- urticaria
Side Effects
- acneiform rash
- adrenocortical insufficiency
- cataracts
- contact dermatitis
- Cushing’s syndrome
- erythema
- folliculitis
- glycosuria
- growth inhibition
- headache
- hyperglycemia
- hypertension
- hypertrichosis
- hypothalamic-pituitary-adrenal (HPA) suppression
- impaired wound healing
- increased intracranial pressure
- infection
- influenza
- maculopapular rash
- miliaria
- ocular hypertension
- papilledema
- paresthesias
- pharyngitis
- pruritus
- pseudotumor cerebri
- purpura
- rash
- skin atrophy
- skin hypopigmentation
- skin irritation
- skin ulcer
- striae
- telangiectasia
- tolerance
- visual impairment
- withdrawal
- xerosis
Monitoring Parameters
- laboratory monitoring not necessary
Contraindications
- acne rosacea
- acne vulgaris
- breast-feeding
- cataracts
- children
- corticosteroid hypersensitivity
- Cushing’s syndrome
- diabetes mellitus
- fungal infection
- geriatric
- glaucoma
- growth inhibition
- herpes infection
- hypothalamic-pituitary-adrenal (HPA) suppression
- increased intracranial pressure
- infants
- infection
- measles
- neonates
- occlusive dressing
- ocular exposure
- perioral dermatitis
- peripheral vascular disease
- pregnancy
- skin abrasion
- skin atrophy
- tobacco smoking
- tuberculosis
- varicella
- viral infection
Interactions
There are no drug interactions associated with Halobetasol products.
